Equi-Flu VEWT

This page contains information on Equi-Flu VEWT for veterinary use.
The information provided typically includes the following:
  • Equi-Flu VEWT Indications
  • Warnings and cautions for Equi-Flu VEWT
  • Direction and dosage information for Equi-Flu VEWT

Equi-Flu VEWT

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Encephalomyelitis-Influenza Vaccine Eastern, Western, and Venezuelan, Killed Virus, Tetanus Toxoid

Equi-Flu VEWT Indications

For the vaccination of all types and ages of healthy horses against Eastern, Western, and Venezuelan Equine Encephalomyelitis, tetanus and as an aid in the prevention of Equine Influenza due to strains A1 and A2 viruses.

Administration and Dosage: Shake well. Using aseptic technique, inject 2 mL deep intramuscularly with a 1 1/2 inch sterile needle preferably in the hind quarters. For primary vaccination administer a second 2 mL dose in 4 to 6 weeks using a different injection site and separate sterile 1 1/2 inch needle for each injection.

Revaccination: Revaccinate annually for protection against tetanus, using a single 2 mL dose. Revaccinate annually and prior to anticipated exposure for maximum benefit against Equine Influenza strains A1 and A2 viruses and Eastern, Western, and Venezuelan Equine Encephalomyelitis. In the event of an outbreak, vaccination should be combined with good hygiene and segregation of affected or newly acquired animals.

Equi-Flu VEWT Caution

Store at 35-45°F (2-7°C). Protect from freezing. Use entire contents when first opened. Contains gentamicin and thimerosal as preservatives. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use.

Antidote: Epinephrine.

Precaution: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal healthy animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

For Veterinary Use Only

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

U.S. Veterinary License No. 124

Code

 

 

131-615

1 Dose/2 mL

31602-03, 31601-03

131-625

10 Doses/20 mL

31604-04, 31603-02

NAC No.: 10280463

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.productionvalues.us
    www.prrsresearch.com
    www.thinkmetacam.com
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Equi-Flu VEWT information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web3)